Studies of α-synuclein Oligomers-with Relevance to Lewy Body Disorders

Studies of α-synuclein Oligomers-with Relevance to Lewy Body Disorders

The protein alpha-synuclein (α-synuclein) accumulates in the brain in disorders such as Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). It is believed that the monomeric form of α-synuclein can adopt a partially folded structure and start to aggregate and form intermediately sized olig...

Full description

Bibliographic Details
Main Author:	Fagerqvist, Therese
Format:	Doctoral Thesis
Language:	English
Published:	Uppsala universitet, Institutionen för folkhälso- och vårdvetenskap 2013
Subjects:	Alpha-synuclein Parkinson´s disease Lewy body dementia Oligomer Monoclonal antibody Immunotherapy Reactive aldehydes
Online Access:	http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-204466 http://nbn-resolving.de/urn:isbn:978-91-554-8720-1

Similar Items

Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers
by: Tomohiro Umeda, et al.
Published: (2021-08-01)

Alpha-synuclein oligomers - neurotoxic molecules in Parkinson’s disease and other Lewy body disorders
by: Martin Ingelsson
Published: (2016-09-01)

Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy
by: Omar El-Agnaf, et al.
Published: (2017-08-01)

Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology
by: Nishant N. Vaikath, et al.
Published: (2015-07-01)

Physiological and Pathological Characterization of Alpha-Synuclein Oligomers
by: Luth, Eric Sloan
Published: (2014)

Progress of immunotherapy of anti-α-synuclein in Parkinson’s disease
by: Zhipeng Wang, et al.
Published: (2019-07-01)

Exosomal cell-to-cell transmission of alpha synuclein oligomers
by: Danzer Karin M, et al.
Published: (2012-08-01)

Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies
by: Attems, J., et al.
Published: (2022)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
by: Xiao-yu Du, et al.
Published: (2020-11-01)

Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
by: P.G. Foulds, et al.
Published: (2012-01-01)

Initiation and propagation of α-synuclein aggregation in the nervous system
by: Baraa A. Hijaz, et al.
Published: (2020-03-01)

How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology
by: Senthil T. Kumar, et al.
Published: (2020-12-01)

Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies
by: Christopher Hatton, et al.
Published: (2020-07-01)

Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
by: Julia E. Gerson, et al.
Published: (2018-03-01)

Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models
by: Andreas Weihofen, et al.
Published: (2019-04-01)

Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models
by: Michiyo Iba, et al.
Published: (2020-07-01)

Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression
by: Zachary A. Sorrentino, et al.
Published: (2019-09-01)

Alpha-Synuclein Oligomers : Cellular Mechanisms and Aspects of Antibody Treatment
by: Gustafsson, Gabriel
Published: (2017)

Effects of α-synuclein on axonal transport
by: Laura A. Volpicelli-Daley
Published: (2017-09-01)

Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
by: Allison J. Schaser, et al.
Published: (2020-08-01)

Dementia with Lewy bodies: an update and outlook
by: Tiago Fleming Outeiro, et al.
Published: (2019-01-01)

Parkinson’s Disease Dementia and Dementia with Lewy Bodies Have Similar Neuropsychological Profiles
by: Georgina M. Aldridge, et al.
Published: (2018-03-01)

Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders
by: Nelson de Oliveira Manzanza, et al.
Published: (2021-06-01)

Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes
by: Gabriel Gustafsson, et al.
Published: (2017-12-01)

Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions
by: Lindsay E. Stoyka, et al.
Published: (2020-02-01)

Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies
by: Connor Bargar, et al.
Published: (2021-04-01)

The Role of Lipids in the Initiation of α-Synuclein Misfolding
by: Martin Kiechle, et al.
Published: (2020-09-01)

Brain-derived exosomes from dementia with Lewy bodies propagate α-synuclein pathology
by: Jennifer Ngolab, et al.
Published: (2017-06-01)

Identifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson’s Disease
by: Ning Shen, et al.
Published: (2019-05-01)

Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
by: Carroll Rutherford Fields, et al.
Published: (2019-12-01)

Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo
by: Darren J. Schofield, et al.
Published: (2019-12-01)

Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer’s disease and dementia with Lewy bodies from the prodromal stage
by: Olivier Bousiges, et al.
Published: (2020-09-01)

Alpha-Synuclein Pathology Coincides With Increased Number of Early Stage Neural Progenitors in the Adult Hippocampus
by: Hannah Bender, et al.
Published: (2021-07-01)

Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson’s Disease
by: Laura Marsal-García, et al.
Published: (2021-01-01)

Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro
by: Janett Köppen, et al.
Published: (2020-01-01)

On α-synuclein in the Human Enteric Nervous System
by: Gray, Madison T.
Published: (2014)

On α-synuclein in the Human Enteric Nervous System
by: Gray, Madison T.
Published: (2014)

The Role of Neutral Sphingolipids in the Pathogenesis of Parkinson Disease and Dementia with Lewy Bodies
by: Singh, Priyanka
Published: (2013)

The Role of Neutral Sphingolipids in the Pathogenesis of Parkinson Disease and Dementia with Lewy Bodies
by: Singh, Priyanka
Published: (2013)

Modeling Parkinson’s Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers
by: Laura Boi, et al.
Published: (2020-11-01)

Cannot write session to /tmp/vufind_sessions/sess_ihl8gqbv1nami171s9rbajv1u0